100632-58-4Relevant articles and documents
Intermediate synthesis process
-
Paragraph 0028-0048, (2018/10/19)
The invention discloses an intermediate synthesis process, which comprises: separately adding 4-(methanesulfonamide)-gamma-oxo phenylbutanoic acid, 1-hydroxybenzotriazole, dicyclohexylcarbodiimide, ethylheptylamine to a solvent dimethyl sulfoxide, dissolv
N-[(ω-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with Class III antiarrhythmic activity
Hester,Gibson,Cimini,Emmert,Locker,Perricone,Skaletzky,Sykes,West
, p. 308 - 315 (2007/10/02)
N-[4-[4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide, (E)-2-butenedioate (2:1) salt (ibutilide fumarate, 2E), has been found to have Class III antiarrhythmic activity. In an in vitro rabbit heart tissue preparation designed to evaluate the